Ipca Laboratories Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Ipca Laboratories Ltd with 125 companies shown from the same industry classification, including Glaxosmithkline Pharmaceuticals Ltd, Gland Pharma Ltd, Ajanta Pharma Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Ipca Laboratories Ltd | 48,726 Cr. | 1,919 | 2,039/1,252 | 35.5 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 49,047 Cr. | 2,896 | 3,121/2,088 | 46.6 | 134 | 1.97 % | 61.4 % | 45.6 % | 10.0 |
| Gland Pharma Ltd | 47,817 Cr. | 2,896 | 3,042/1,574 | 33.8 | 656 | 0.69 % | 17.4 % | 12.8 % | 1.00 |
| Ajanta Pharma Ltd | 44,039 Cr. | 3,525 | 3,797/2,330 | 38.8 | 362 | 0.91 % | 34.5 % | 27.1 % | 2.00 |
| Abbott India Ltd | 57,279 Cr. | 26,955 | 30,655/25,135 | 35.5 | 2,247 | 1.95 % | 44.8 % | 34.4 % | 10.0 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Wockhardt Ltd | 36,814 Cr. | 2,266 | 2,422/1,087 | 92.3 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| Biocon Ltd | 61,282 Cr. | 375 | 447/337 | 84.3 | 210 | 0.13 % | 3.61 % | 1.40 % | 5.00 |
| Alkem Laboratories Ltd | 61,922 Cr. | 5,175 | 5,934/5,051 | 27.2 | 1,156 | 1.02 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 65,554 Cr. | 2,326 | 2,538/1,793 | 21.0 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Life Sciences Ltd | 67,169 Cr. | 2,380 | 2,538/1,793 | 21.5 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Neuland Laboratories Ltd | 27,490 Cr. | 21,440 | 24,235/11,500 | 55.2 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Acutaas Chemicals Ltd | 26,792 Cr. | 3,272 | 3,740/1,290 | 69.4 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Granules India Ltd | 23,153 Cr. | 851 | 924/511 | 35.6 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Caplin Point Laboratories Ltd | 21,688 Cr. | 2,854 | 2,991/1,500 | 32.6 | 443 | 0.28 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 19,821 Cr. | 1,013 | 1,076/260 | 69.7 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Pfizer Ltd | 18,132 Cr. | 3,968 | 5,578/3,925 | 23.6 | 919 | 1.89 % | 24.1 % | 18.0 % | 10.0 |
| Cohance Lifesciences Ltd | 17,571 Cr. | 459 | 918/267 | 163 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| ERIS Lifesciences Ltd | 17,128 Cr. | 1,236 | 1,740/1,200 | 26.1 | 282 | 0.58 % | 14.1 % | 18.7 % | 1.00 |
| Jubilant Pharmova Ltd | 16,858 Cr. | 1,060 | 1,185/784 | 43.4 | 445 | 0.47 % | 8.99 % | 6.53 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,796 Cr. | 854 | 998/635 | 22.5 | 289 | 1.40 % | 12.6 % | 13.4 % | 2.00 |
| Astrazeneca Pharma India Ltd | 15,669 Cr. | 6,280 | 9,850/6,262 | 90.3 | 349 | 0.57 % | 29.3 % | 23.3 % | 2.00 |
| Concord Biotech Ltd | 15,207 Cr. | 1,454 | 1,668/987 | 53.5 | 193 | 0.52 % | 17.4 % | 12.6 % | 1.00 |
| Marksans Pharma Ltd | 15,027 Cr. | 332 | 351/155 | 29.1 | 66.7 | 0.27 % | 18.8 % | 15.2 % | 1.00 |
| Natco Pharma Ltd | 14,827 Cr. | 829 | 1,227/789 | 13.0 | 515 | 0.60 % | 17.4 % | 17.1 % | 2.00 |
| Blue Jet Healthcare Ltd | 10,801 Cr. | 571 | 693/325 | 46.0 | 78.4 | 0.21 % | 26.1 % | 19.4 % | 2.00 |
| Suven Life Sciences Ltd | 9,466 Cr. | 335 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Procter & Gamble Health Ltd | 8,974 Cr. | 5,406 | 6,975/4,700 | 26.9 | 316 | 2.87 % | 83.9 % | 61.9 % | 10.0 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Aarti Pharmalabs Ltd | 8,520 Cr. | 940 | 962/584 | 39.6 | 234 | 0.37 % | 10.7 % | 8.59 % | 5.00 |
| Entero Healthcare Solutions Ltd | 7,929 Cr. | 1,822 | 1,920/944 | 61.4 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,793 Cr. | 738 | 745/118 | 56.6 | 113 | 0.20 % | 16.9 % | 11.8 % | 1.00 |
| Sanofi India Ltd | 7,232 Cr. | 3,140 | 4,898/3,049 | 21.1 | 359 | 2.39 % | 57.5 % | 43.0 % | 10.0 |
| Morepen Laboratories Ltd | 6,611 Cr. | 121 | 127/33.0 | 56.3 | 22.8 | 0.17 % | 8.05 % | 5.33 % | 2.00 |
| Orchid Pharma Ltd | 6,129 Cr. | 1,023 | 1,144/471 | 339 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 5,760 Cr. | 196 | 219/67.1 | 32.6 | 61.3 | 0.51 % | 11.3 % | 8.42 % | 2.00 |
| FDC Ltd | 5,593 Cr. | 344 | 476/313 | 18.2 | 153 | 1.46 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 5,427 Cr. | 417 | 479/225 | 111 | 26.4 | 0.16 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 5,045 Cr. | 3,051 | 3,130/1,731 | 43.2 | 366 | 0.79 % | 25.7 % | 19.3 % | 8.00 |
| Zota Health Care Ltd | 4,629 Cr. | 1,337 | 1,740/1,022 | 200 | 0.07 % | 8.47 % | 15.0 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 4,448 Cr. | 475 | 494/240 | 49.1 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,224 Cr. | 420 | 468/268 | 57.4 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Aarti Drugs Limited | 3,900 Cr. | 430 | 534/319 | 22.5 | 154 | 0.47 % | 11.7 % | 12.7 % | 10.0 |
| Unichem Laboratories Ltd | 3,870 Cr. | 550 | 687/278 | 31.7 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 3,712 Cr. | 3,577 | 3,949/829 | 45.5 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,587 Cr. | 739 | 774/422 | 840 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,547 Cr. | 408 | 420/87.0 | 54.5 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 3,167 Cr. | 283 | 420/252 | 20.1 | 146 | 1.89 % | 14.0 % | 10.2 % | 2.00 |
| Lupin Ltd | 94,383 Cr. | 2,062 | 2,530/1,900 | 15.8 | 491 | 0.87 % | 29.9 % | 28.7 % | 2.00 |
| Dishman Carbogen Amcis Ltd | 2,585 Cr. | 164 | 307/128 | 142 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Hikal Ltd | 2,570 Cr. | 209 | 261/146 | 60.6 | 97.2 | 0.29 % | 3.50 % | 2.21 % | 2.00 |
| Indoco Remedies Ltd | 2,304 Cr. | 249 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Beta Drugs Ltd | 2,262 Cr. | 2,040 | 2,808/990 | 49.6 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Panacea Biotec Ltd | 2,246 Cr. | 366 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Fredun Pharmaceuticals Ltd | 2,244 Cr. | 1,357 | 1,600/427 | 50.5 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Venus Remedies Ltd | 2,230 Cr. | 1,668 | 2,044/424 | 19.2 | 497 | 0.60 % | 21.7 % | 16.8 % | 10.0 |
| Syncom Formulations (India) Ltd | 1,885 Cr. | 20.0 | 22.6/10.2 | 22.2 | 4.39 | 0.50 % | 24.8 % | 17.6 % | 1.00 |
| Hester Biosciences Ltd | 1,826 Cr. | 2,147 | 2,684/1,239 | 34.4 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Jagsonpal Pharmaceuticals Ltd | 1,586 Cr. | 241 | 265/155 | 33.8 | 41.2 | 1.66 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,465 Cr. | 507 | 760/476 | 23.6 | 128 | 0.97 % | 24.8 % | 18.4 % | 1.00 |
| TTK Healthcare Ltd | 1,457 Cr. | 1,031 | 1,250/735 | 19.0 | 789 | 0.97 % | 8.04 % | 6.30 % | 10.0 |
| Fermenta Biotech Ltd | 1,379 Cr. | 468 | 580/249 | 25.2 | 138 | 0.80 % | 20.6 % | 16.4 % | 5.00 |
| Kopran Ltd | 1,342 Cr. | 278 | 294/107 | 53.7 | 110 | 1.08 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,167 Cr. | 582 | 770/440 | 12.1 | 378 | 0.31 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,077 Cr. | 117 | 147/65.0 | 43.3 | 0.43 % | 2.74 % | 0.41 % | 1.00 | |
| Anuh Pharma Ltd | 906 Cr. | 90.4 | 99.5/66.7 | 20.5 | 35.1 | 1.66 % | 14.9 % | 10.7 % | 5.00 |
| Bafna Pharmaceuticals Ltd | 831 Cr. | 357 | 363/94.8 | 107 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Wanbury Ltd | 784 Cr. | 224 | 360/162 | 18.2 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Kilitch Drugs (India) Ltd | 761 Cr. | 217 | 234/117 | 25.3 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Albert David Ltd | 485 Cr. | 847 | 932/580 | 21.5 | 686 | 0.59 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 314 Cr. | 102 | 104/50.3 | 75.2 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| Lyka Labs Ltd | 304 Cr. | 84.1 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| BDH Industries Ltd | 282 Cr. | 490 | 610/340 | 24.1 | 134 | 1.02 % | 20.5 % | 14.8 % | 10.0 |
| Gennex Laboratories Ltd | 245 Cr. | 10.1 | 17.2/7.05 | 13.0 | 9.16 | 0.00 % | 10.8 % | 9.25 % | 1.00 |
| Everest Organics Ltd | 228 Cr. | 229 | 536/197 | 43.4 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Nectar Lifescience Ltd | 210 Cr. | 10.7 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Coral Laboratories Ltd | 201 Cr. | 563 | 679/360 | 10.6 | 585 | 0.36 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 167 Cr. | 105 | 125/59.7 | 23.1 | 51.6 | 1.15 % | 9.69 % | 7.87 % | 10.0 |
| Brooks Laboratories Ltd | 167 Cr. | 56.6 | 144/36.3 | 12.6 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Achyut Healthcare Ltd | 164 Cr. | 6.79 | 10.0/4.70 | 512 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Par Drugs & Chemicals Ltd | 160 Cr. | 130 | 180/78.0 | 11.0 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Auro Laboratories Ltd | 150 Cr. | 241 | 317/159 | 31.4 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Lactose (India) Ltd | 142 Cr. | 112 | 136/76.0 | 20.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 138 Cr. | 9.45 | 14.3/1.96 | 46.1 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Godavari Drugs Ltd | 137 Cr. | 125 | 135/69.7 | 35.1 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Alpa Laboratories Ltd | 124 Cr. | 59.2 | 99.8/46.0 | 28.4 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 120 Cr. | 57.6 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Vaishali Pharma Ltd | 112 Cr. | 8.62 | 12.0/4.75 | 26.5 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 107 Cr. | 30.4 | 66.0/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Concord Drugs Ltd | 103 Cr. | 78.3 | 92.5/61.0 | 50.6 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 96.3 Cr. | 69.4 | 97.4/56.1 | 12.1 | 66.0 | 3.60 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 76.8 Cr. | 15.4 | 26.0/13.0 | 21.1 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 56.6 Cr. | 22.6 | 22.6/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 56.2 Cr. | 13.0 | 22.6/12.8 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| ANG Lifesciences India Ltd | 52.6 Cr. | 40.3 | 49.7/17.6 | 47.6 | 0.00 % | 0.95 % | 7.33 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 50.8 Cr. | 31.5 | 46.8/25.6 | 106 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Mangalam Drugs and Organics Ltd | 48.8 Cr. | 30.9 | 77.9/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Vivimed Labs Ltd | 46.0 Cr. | 5.55 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.60/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bacil Pharma Ltd | 37.7 Cr. | 26.3 | 61.8/10.6 | 58.0 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 37.3 Cr. | 49.4 | 53.0/29.7 | 12.2 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 30.6 Cr. | 39.3 | 59.8/29.0 | 13.8 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Checkpoint Trends Ltd | 18.0 Cr. | 32.9 | 144/28.4 | 14.6 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Dipna Pharmachem Ltd | 12.4 Cr. | 4.73 | 25.0/3.90 | 4.73 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Beryl Drugs Ltd | 11.8 Cr. | 23.2 | 27.6/15.9 | 19.0 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.2 Cr. | 74.3 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Colinz Laboratories Ltd | 9.60 Cr. | 76.2 | 87.9/36.1 | 19.2 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Adline Chem Lab Ltd | 8.80 Cr. | 15.0 | 17.1/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 6.45 Cr. | 21.5 | 24.4/17.7 | 7.59 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 6.06 Cr. | 6.00 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.35 Cr. | 0.81 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.64 Cr. | 1.46 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Aurobindo Pharma Ltd | 98,505 Cr. | 1,712 | 1,740/1,066 | 26.0 | 652 | 0.23 % | 12.9 % | 10.1 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,01,762 Cr. | 1,221 | 1,415/1,080 | 31.6 | 454 | 0.66 % | 13.0 % | 11.2 % | 1.00 |
| Mankind Pharma Ltd | 1,02,225 Cr. | 2,475 | 2,642/1,910 | 45.2 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Laurus Labs Ltd | 1,08,966 Cr. | 2,011 | 2,055/826 | 125 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Cipla Ltd | 1,11,985 Cr. | 1,384 | 1,673/1,166 | 31.3 | 426 | 0.94 % | 15.5 % | 11.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,89,746 Cr. | 4,988 | 5,250/3,480 | 85.0 | 248 | 0.76 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,905.32 Cr | 1,266.63 | 56.43 | 211.60 | 0.38% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Ipca Laboratories Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Ipca Laboratories Ltd analysis · Explore all Pharmaceuticals stocks